Novel Drug Regimen Can Improve Stem Cell Transplantation Outcomes – Science Daily (press release)
|
Novel Drug Regimen Can Improve Stem Cell Transplantation Outcomes
Science Daily (press release) Dec. 9, 2013 — Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers … Stem Cell Transplants can be improved by New Drug RegimenTopNews United States |
